BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 31113175)

  • 21. The prognostic significance of the neutrophil-to-lymphocyte ratio and the platelet-to-lymphocyte ratio in giant cell tumor of the extremities.
    Chen Z; Zhao G; Chen F; Xia J; Jiang L
    BMC Cancer; 2019 Apr; 19(1):329. PubMed ID: 30961549
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The prognostic value of neutrophil-lymphocyte ratio is superior to derived neutrophil-lymphocyte ratio in advanced gastric cancer treated with preoperative chemotherapy and sequential R0 resection: a 5-year follow-up.
    Jin H; Sun J; Zhu K; Liu X; Zhang Q; Shen Q; Gao Y; Yu J
    Onco Targets Ther; 2017; 10():2655-2664. PubMed ID: 28579803
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pretreatment blood biomarkers combined with magnetic resonance imaging predict responses to neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
    Shi X; Zhao M; Shi B; Chen G; Yao H; Chen J; Wan D; Gu W; He S
    Front Oncol; 2022; 12():916840. PubMed ID: 36016621
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elevated platelet count is a negative predictive and prognostic marker in locally advanced rectal cancer undergoing neoadjuvant chemoradiation: a retrospective multi-institutional study on 965 patients.
    Belluco C; Forlin M; Delrio P; Rega D; Degiuli M; Sofia S; Olivieri M; Pucciarelli S; Zuin M; De Manzoni G; Di Leo A; Scabini S; Zorcolo L; Restivo A
    BMC Cancer; 2018 Nov; 18(1):1094. PubMed ID: 30419864
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pretreatment Neutrophil-to-Lymphocyte Ratio Associated with Tumor Recurrence and Survival in Patients Achieving a Pathological Complete Response Following Neoadjuvant Chemoradiotherapy for Rectal Cancer.
    Huang CM; Huang MY; Tsai HL; Huang CW; Su WC; Chang TK; Chen YC; Li CC; Wang JY
    Cancers (Basel); 2021 Sep; 13(18):. PubMed ID: 34572816
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preoperative neutrophil-to-lymphocyte ratio as a prognosticator in early stage pancreatic ductal adenocarcinoma.
    Abe T; Amano H; Kobayashi T; Hanada K; Nakahara M; Ohdan H; Noriyuki T
    Eur J Surg Oncol; 2018 Oct; 44(10):1573-1579. PubMed ID: 29807728
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of immunologic markers from complete blood counts with the response to preoperative chemoradiotherapy and prognosis in locally advanced rectal cancer.
    Jung SW; Park IJ; Oh SH; Yeom SS; Lee JL; Yoon YS; Kim CW; Lim SB; Lee JB; Yu CS; Kim JC
    Oncotarget; 2017 Aug; 8(35):59757-59765. PubMed ID: 28938679
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neutrophil-to-Lymphocyte Ratio in Rectal Cancer-Novel Biomarker of Tumor Immunogenicity During Radiotherapy or Confounding Variable?
    Braun LH; Baumann D; Zwirner K; Eipper E; Hauth F; Peter A; Zips D; Gani C
    Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31108935
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictive Value of Leukocyte- and Platelet-Derived Ratios in Rectal Adenocarcinoma.
    Ward WH; Goel N; Ruth KJ; Esposito AC; Lambreton F; Sigurdson ER; Meyer JE; Farma JM
    J Surg Res; 2018 Dec; 232():275-282. PubMed ID: 30463730
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preoperative neutrophil-to-lymphocyte ratio predicts recurrence of esophageal squamous cell carcinoma after neoadjuvant triplet chemotherapy.
    Kubo K; Igaue S; Utsunomiya D; Kubo Y; Kanematsu K; Kurita D; Ishiyama K; Oguma J; Goto K; Daiko H
    Gen Thorac Cardiovasc Surg; 2024 Jun; ():. PubMed ID: 38913280
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Associations of Preoperative Platelet-to-lymphocyte Ratio and Derived Neutrophil-to-lymphocyte Ratio with thePrognosis of Gastrointestinal Stromal Tumor].
    Yin XN; Tang SM; Yin Y; Shen CY; Zhang B; Chen ZX
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2017 Mar; 48(2):239-243. PubMed ID: 28612534
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictive clinical model of tumor response after chemoradiation in rectal cancer.
    Santos MD; Silva C; Rocha A; Nogueira C; Castro-Poças F; Araujo A; Matos E; Pereira C; Medeiros R; Lopes C
    Oncotarget; 2017 Aug; 8(35):58133-58151. PubMed ID: 28938543
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predicting Pathological Complete Regression with Haematological Markers During Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer.
    Lee JH; Song C; Kang SB; Lee HS; Lee KW; Kim JS
    Anticancer Res; 2018 Dec; 38(12):6905-6910. PubMed ID: 30504408
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The predictive value of peripheral blood cells and lymphocyte subsets in oesophageal squamous cell cancer patients with neoadjuvant chemoradiotherapy.
    Zhou J; Lin HP; Xu X; Wang XH; Rong L; Zhang Y; Shen L; Xu L; Qin WT; Ye Q; Ma XM; Bai YR
    Front Immunol; 2022; 13():1041126. PubMed ID: 36451825
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictive significance of cancer related-inflammatory markers in locally advanced rectal cancer.
    Timudom K; Akaraviputh T; Chinswangwatanakul V; Pongpaibul A; Korpraphong P; Petsuksiri J; Ithimakin S; Trakarnsanga A
    World J Gastrointest Surg; 2020 Sep; 12(9):390-396. PubMed ID: 33024513
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel predictive model based on preoperative blood neutrophil-to-lymphocyte ratio for survival prognosis in patients with gastric neuroendocrine neoplasms.
    Cao LL; Lu J; Lin JX; Zheng CH; Li P; Xie JW; Wang JB; Chen QY; Lin M; Tu RH; Huang CM
    Oncotarget; 2016 Jul; 7(27):42045-42058. PubMed ID: 27275541
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Systemic inflammatory response is a predictor of outcome in patients undergoing preoperative chemoradiation for locally advanced rectal cancer.
    Carruthers R; Tho LM; Brown J; Kakumanu S; McCartney E; McDonald AC
    Colorectal Dis; 2012 Oct; 14(10):e701-7. PubMed ID: 22731833
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical and Prognostic Significance of Pathological and Inflammatory Markers in Mucinous Rectal Cancer Patients Receiving Neoadjuvant Chemoradiotherapy and Curative Surgery.
    Zhao J; Xu J; Zhang R
    Med Sci Monit; 2017 Oct; 23():4826-4833. PubMed ID: 28988257
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neutrophil-lymphocyte ratio predicts pathologic tumor response and survival after preoperative chemoradiation for rectal cancer.
    Kim IY; You SH; Kim YW
    BMC Surg; 2014 Nov; 14():94. PubMed ID: 25406793
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Preoperative Neutrophil-To-Lymphocyte Ratio Is a Novel Immune Parameter for the Prognosis of Esophageal Basaloid Squamous Cell Carcinoma.
    Xiao Q; Zhang B; Deng X; Wu J; Wang H; Wang Y; Wang W
    PLoS One; 2016; 11(12):e0168299. PubMed ID: 27959959
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.